1.
Ktena YP, Burris M, Berger R, Duke K, Newton S, Rodenbush K, Murphy JD, Vindiola L, Cooke LM, Tsai H-L, Bonifant CL, Chen AR, Gamper CJ, Llosa NJ, Zambidis ET, Liddle K, Jones RJ, BolaƱos-Meade J, Symons HJ, Cooke KR. Reduced intensity hematopoietic cell transplant using best available donor and post-transplant cyclophosphamide is safe and curative for transfusion-dependent thalassemia. Haematologica; https://doi.org/10.3324/haematol.2026.301748 [Early view].